Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
Source: https://www.nytimes.com/2026/05/30/business/china-lung-cancer-drugs-asco.html
About the Author
